loadpatents
Patent applications and USPTO patent grants for Feldhaus; Andrew L..The latest application filed is for "anti-il-6 antibodies for the treatment of oral mucositis".
Patent | Date |
---|---|
Anti-il-6 Antibodies For The Treatment Of Oral Mucositis App 20210332126 - SMITH; Jeffrey T.L. ;   et al. | 2021-10-28 |
Antibodies To Hgf And Compositions Containing App 20190085066 - Dutzar; Benjamin H. ;   et al. | 2019-03-21 |
Anti-il-6 Antibodies For The Treatment Of Oral Mucositis App 20190023780 - SMITH; Jeffrey T.L. ;   et al. | 2019-01-24 |
Antibodies to HGF and compositions containing Grant 10,100,108 - Dutzar , et al. October 16, 2 | 2018-10-16 |
Anti-IL-6 antibodies for the treatment of oral mucositis Grant 9,957,321 - Smith , et al. May 1, 2 | 2018-05-01 |
Therapeutic use of antibodies to HGF Grant 9,732,150 - Garcia-Martinez , et al. August 15, 2 | 2017-08-15 |
Antibodies To Hgf And Compositions Containing App 20170107280 - Dutzar; Benjamin H. ;   et al. | 2017-04-20 |
Antibodies to HGF and compositions containing Grant 9,481,725 - Dutzar , et al. November 1, 2 | 2016-11-01 |
Anti-il-6 Antibodies For The Treatment Of Oral Mucositis App 20150368337 - Smith; Jeffrey T.L. ;   et al. | 2015-12-24 |
Anti-IL-6 antibodies for the treatment of oral mucositis Grant 8,992,908 - Smith , et al. March 31, 2 | 2015-03-31 |
Therapeutic Use Of Antibodies To Hgf App 20140271464 - GARCIA-MARTINEZ; Leon F. ;   et al. | 2014-09-18 |
Antibodies To Hgf And Compositions Containing App 20140271459 - Dutzar; Benjamin H. ;   et al. | 2014-09-18 |
Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors App 20060019382 - Feldhaus; Andrew L. | 2006-01-26 |
Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors Grant 6,936,466 - Feldhaus August 30, 2 | 2005-08-30 |
Murine interferon-.alpha. Grant 6,902,729 - Presnell , et al. June 7, 2 | 2005-06-07 |
Adipocyte complement related protein zacrp11 App 20050048615 - Fox, Brian A. ;   et al. | 2005-03-03 |
Adipocyte complement related protein zacrp12 App 20050032700 - Fox, Brian A. ;   et al. | 2005-02-10 |
Murine interferon-alpha App 20030147851 - Presnell, Scott R. ;   et al. | 2003-08-07 |
Testis protein, Zsig86 App 20020192777 - Sheppard, Paul O. ;   et al. | 2002-12-19 |
Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors App 20020164783 - Feldhaus, Andrew L. | 2002-11-07 |
Testis specific protein App 20020151492 - Conklin, Darrell C. ;   et al. | 2002-10-17 |
Transcriptionally-activated AAV inverted terminal repeats (ITRS) for use with recombinant AAV vectors Grant 6,346,415 - Feldhaus February 12, 2 | 2002-02-12 |
Murine interferon-.alpha. Grant 6,312,924 - Presnell , et al. November 6, 2 | 2001-11-06 |
Testis-specific cystatin-like protein cystatin T Grant 6,235,708 - Holloway , et al. May 22, 2 | 2001-05-22 |
CD69 transcriptional regulatory elements Grant 5,759,805 - Feldhaus , et al. June 2, 1 | 1998-06-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.